Skip to main content
. 2018 Jul 9;53(3):1043–1054. doi: 10.3892/ijo.2018.4477

Figure 7.

Figure 7

Antiproliferative effects of NT21MP and miR-155-3p/5p on human breast cancer MCF-7 cells. (A) Antiproliferative effects of NT21MP and miR-155-3p mimics on human breast cancer MCF-7 cells. (B) Antiproliferative effects of NT21MP and miR-155-5p inhibitor on human breast cancer MCF-7 cells. The cells were treated with various concentrations of paclitaxel for 72 h, and then analyzed for viability using a Cell Counting kit-8 assay. Absorbance at 450 nm is presented as the mean ± standard deviation. The results are representative of three independent experiments performed in triplicate. NT21MP; 21-residue peptide derived from viral macrophage inflammatory protein II; PR, paclitaxel-resistant; miR, microRNA.